Literature DB >> 14668817

Analysing differential gene expression in cancer.

Peng Liang1, Arthur B Pardee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14668817     DOI： 10.1038/nrc1214

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  32 in total

1.  Global analysis of gene expression by differential display: a mathematical model.

Authors:  Shitao Yang; Peng Liang
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

Review 2.  Network biology methods integrating biological data for translational science.

Authors:  Gurkan Bebek; Mehmet Koyutürk; Nathan D Price; Mark R Chance
Journal:  Brief Bioinform       Date:  2012-03-05       Impact factor: 11.622

Review 3.  S-phase-coupled apoptosis in tumor suppression.

Authors:  Yong-Jig Cho; Peng Liang
Journal:  Cell Mol Life Sci       Date:  2011-03-25       Impact factor: 9.261

Review 4.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

5.  Cell cycle specific distribution of killin: evidence for negative regulation of both DNA and RNA synthesis.

Authors:  Man Qiao; Dan Luo; Yi Kuang; Haiyan Feng; Guangping Luo; Peng Liang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Killin is a p53-regulated nuclear inhibitor of DNA synthesis.

Authors:  Yong-Jig Cho; Peng Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

7.  Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine.

Authors:  V Uma Bai; Ahmed Kaseb; Sheela Tejwani; George W Divine; Evelyn R Barrack; Mani Menon; Arthur B Pardee; G Prem-Veer Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

8.  Targeting the human cancer pathway protein interaction network by structural genomics.

Authors:  Yuanpeng Janet Huang; Dehua Hang; Long Jason Lu; Liang Tong; Mark B Gerstein; Gaetano T Montelione
Journal:  Mol Cell Proteomics       Date:  2008-05-18       Impact factor: 5.911

Review 9.  Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.

Authors:  Liming Weng; Li Zhang; Yan Peng; R Stephanie Huang
Journal:  Pharmacogenomics       Date:  2013-02       Impact factor: 2.533

10.  3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.

Authors:  Andrew H Beck; Ziming Weng; Daniela M Witten; Shirley Zhu; Joseph W Foley; Phil Lacroute; Cheryl L Smith; Robert Tibshirani; Matt van de Rijn; Arend Sidow; Robert B West
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.